Spur Cell Anemia Medication
- Author: Christopher D Braden, DO; Chief Editor: Emmanuel C Besa, MD more...
Medication Summary
Because patients with abetalipoproteinemia cannot absorb triglycerides, a diet restricted in these nutrients may result in significant improvement of symptoms. Supplementation of the diet with lipid-soluble vitamins A, K, E, and D results in further improvement of neurologic and retinal symptoms.
Vitamins, Fat-Soluble
Class Summary
Vitamins are used to meet necessary dietary requirements and are used in metabolic pathways, as well as DNA and protein synthesis.
Vitamin A (Aquasol A, A-Natural-25, A-25)
Vitamin A is a cofactor in many biochemical processes.
Vitamin E (Alph-E, E-Gems, Aquasol E, Gamma-E Gems)
Vitamin E protects polyunsaturated fatty acids in membranes from attack by free radicals and protects red blood cells from hemolysis.
Phytonadione (MEPHYTON)
Vitamin K is a fat-soluble vitamin absorbed by the gut and stored in the liver. It is necessary for the function of clotting factors in the coagulation cascade. Phytonadione is used to replace the essential vitamin K forms not obtained in sufficient quantities in the diet or to further supplement levels.
Cholecalciferol (Vitamin D3, Bio-D-Mulsion Forte, Delta D3)
This agent stimulates absorption of calcium and phosphate from small intestine and promotes release of calcium from bone into blood. Use for treatment of vitamin D deficiency or prophylaxis of vitamin D deficiency.
Doll DC, Doll NJ. Spur cell anemia. South Med J. Oct 1982;75(10):1205-10. [Medline].
Haruta I, Hashimoto E, Kabutake A, et al. Spur cell anemia associated with a cirrhotic non-alcoholic steatohepatitis patient. Hepatol Res. Jun 2007;37(6):482-5. [Medline].
Shohet SB, Ness PM. Hemolytic anemias. Failure of the red cell membrane. Med Clin North Am. Sep 1976;60(5):913-32. [Medline].
Cooper RA. Hemolytic syndromes and red cell membrane abnormalities in liver disease. Semin Hematol. Apr 1980;17(2):103-12. [Medline].
Cynamon HA, Isenberg JN, Gustavson LP, Gourley WK. Erythrocyte lipid alterations in pediatric cholestatic liver disease: spur cell anemia of infancy. J Pediatr Gastroenterol Nutr. Aug 1985;4(4):542-9. [Medline].
Olivieri O, Guarini P, Negri M, et al. Increased proteolytic activity of erythrocyte membrane in spur cell anaemia. Br J Haematol. Dec 1988;70(4):483-9. [Medline].
Arienti G, Carlini E, Scionti L, Puxeddu E, Brunetti P. Liver alcoholic cirrhosis and spur-cell (acanthocytic) anaemia. A study of erythrocyte ghost composition and fluidity. Scand J Gastroenterol. Dec 1995;30(12):1204-9. [Medline].
Wong P. A basis of the acanthocytosis in inherited and acquired disorders. Med Hypotheses. 2004;62(6):966-9. [Medline].
Redman CM, Russo D, Lee S. Kell, Kx and the McLeod syndrome. Baillieres Best Pract Res Clin Haematol. Dec 1999;12(4):621-35. [Medline].
Terada N, Fujii Y, Ueda H, et al. Ultrastructural changes of erythrocyte membrane skeletons in chorea-acanthocytosis and McLeod syndrome revealed by the quick-freezing and deep-etching method. Acta Haematol. Mar 1999;101(1):25-31. [Medline].
Chitale AA, Sterling RK, Post AB, et al. Resolution of spur cell anemia with liver transplantation: a case report and review of the literature. Transplantation. Apr 15 1998;65(7):993-5. [Medline].

